Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-09-19

FDA Approved: PALONOSETRON HYDROCHLORIDE — Original Application (Sagent Pharmaceuticals)

View source ↗

Summary

FDA approved Palonosetron hydrochloride as a generic product through an Original Application filed by Sagent Pharmaceuticals.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Palonosetron hydrochloride (Palonosetron hydrochloride)

Snippet

ORIG AP for PALONOSETRON HYDROCHLORIDE (PALONOSETRON HYDROCHLORIDE)